
Ronjon Nag Ph.D.
Scientific Advisor
Dr. Ronjon Nag is Founder of R42 Group, inventor, and Adjunct Prof. in Genetics, Stanford Medicine. He is a renowned inventor, entrepreneur, and educator, building AI systems for over 40 years. He has founded and advised companies that have been sold to Motorola, RIM/BlackBerry, and Apple, pioneering speech and handwriting recognition, and mobile app stores. More recently, as Founder of R42 Group, he has been inventing and investing at the intersection of AI and medicine, creating Superbio.ai (an AI life science app store) and Agemica (a vaccine for aging). Additionally, he provides free AI education through the R42 Institute.
In 2016, he became a Stanford Interdisciplinary Distinguished Careers Institute Fellow and teaches courses on AI, genes, ethics, longevity science, and venture capital. Ronjon is a Fellow and Trustee of the Institution of Engineering and Technology (IET), a Lifetime Member of the Association for Computing Machinery (ACM) and a Senior Member of the IEEE.
He entered the Silicon Valley Engineering Hall of Fame in 2024 and received the IET Mountbatten Medal, the Verizon Powerful Answers Award ($1 million prize), the 2023 MIT Great Dome Award, the 2023 COGX AI Lifetime Achievement Award, and the 2021 IEEE-Santa Clara Valley Outstanding Engineer Award. He received a PhD from Cambridge, an MS from MIT, a BSc from Birmingham University (UK) and was a Harkness Post-Doctoral Fellow at Stanford University.
Dr. Nag is also part owner of some 100 AI and Biotech start-ups. His current focus is on using AI to solve the problem of aging.